Baldwin Insurance Group (NASDAQ:BWIN) Posts Q2 CY2026 Sales In Line With Estimates

Insurance distribution company Baldwin Insurance Group (NASDAQ: BWIN) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 30.1% year on year to $492.9 million. Its non-GAAP profit of $0.48 per share was in line with analysts’ consensus estimates. Is now the time to buy Baldwin Insurance Group? Find out by accessing our full research report, it’s free.

Original reporting
Published Jul 30, 2026, 9:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 9:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Baldwin Insurance Group (NASDAQ:BWIN) Posts Q2 CY2026 Sales In Line With Estimates — source image
Decision brief

The 30-second read

$BWINNeutralLow
01

Why it matters

The key trade question is whether the market will treat the quarter as a clean execution (in-line revenue and EPS) or as evidence of worsening profitability and weaker organic demand.

02

Market read

Q2 CY2026 results were described as in line, with the stock flat immediately after, but organic revenue missed and adjusted operating margin remained negative.

03

What to watch

The article highlights negative adjusted operating margin and dilution (share count up 108%), but does not quantify cash flow or balance-sheet changes that could offset earnings quality concerns.

Relevance 4/10Novelty 4/10Timing: after-hours/next-session reaction to Q2 CY2026 results

Background

Baldwin Insurance Group, rebranded from BRP Group in May 2024, is an independent insurance distribution firm reporting Q2 CY2026 results.

Company-level read

Ticker impact

$BWINNeutralMedium confidence
Context

Baldwin Insurance Group reported Q2 CY2026 revenue of $492.9M and adjusted EPS of $0.48, both described as in line with consensus.

Expected impact

Likely limited near-term upside from the print itself; focus shifts to margin trajectory and organic growth versus the next 12-month outlook.

Evidence & confidence

The article states revenue and EPS were in line, stock was flat at $26.70 immediately after results, while adjusted operating margin was negative and organic revenue missed.

Market effects

Signals that insurance distribution peers may still face margin pressure and reliance on non-organic factors to drive headline growth.

None explicitly indicated.

None explicitly indicated.

Counterpoint

In-line EPS with strong headline revenue growth could still support the stock if investors were positioned for a miss, especially if organic weakness is temporary.

Key entities

  • Baldwin Insurance Group

    NASDAQ-listed insurance distribution company reporting Q2 CY2026 revenue and adjusted EPS in line with estimates.

Related articles

$BWINMedAI 8/10

CAC acquisition drives Baldwin's 30% revenue jump in Q2

Baldwin reported Q2 2026 commissions and fees of $488.8 million, up 30% from $376.2 million a year earlier, driven largely by its January 2026 CAC Group acquisition. Organic revenue growth was 2% (vs 11% in Q2 2025). IAS organic growth was -2%, while UCTS grew 6% and MIS grew 4%. GAAP net loss was $56 million. Q3 revenue guidance is $485–$495 million with mid-single-digit organic growth.

$BWINMedAI 8/10

Baldwin (BWIN) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Executive Director of Investor Relations - Bonnie Bishop Chief Executive Officer - Trevor Lowry Baldwin Chief Financial Officer - Bradford Lenzie Hale TAKEAWAYS Revenue -- $493 million, representing 2% total organic revenue growth during the period. Adjusted EBITDA -- $117 million, compared to $86 million in the prior-year period.

$BWINMed

Baldwin Insurance Group, Inc. (BWIN): Results of Operations and Financial Condition

Baldwin Insurance Group, Inc. (BWIN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1fy2026q2earningsrele.htm EX-99.1 Document Exhibit 99.1 THE BALDWIN GROUP ANNOUNCES SECOND QUARTER 2026 RESULTS — Second Quarter Total Revenue Growth of 30% to $492.9 Million — — Second Quarter Net Loss of $56.0 Million; Adjusted EBITDA (1) Growth of 37% to $116.7

$PLTRMed

Stocks Erase Early Gains as Alphabet and Software Companies Fall

US stocks gave back early gains as software and defense shares fell. Alphabet dropped over 6% after Google DeepMind VP Jumper said to be leaving for Anthropic. Defense names slid after Iran said it made “major progress” with the US on a peace deal. Rates: 10-year Treasury yield rose to 4.489% amid $211B in auctions. Semiconductors and AI stocks led gains; Palantir, Intuit, Oracle fell, while SOXX hit a record.